Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr.

Arch Intern Med. 2009 Jul 13;169(13):1195-202. doi: 10.1001/archinternmed.2009.175.

2.

Centrally Active ACEIs and cognitive decline.

Asamura T, Ohrui T, Une K, Furukawa K, Arai H.

Arch Intern Med. 2010 Jan 11;170(1):107-8; author reply 108. doi: 10.1001/archinternmed.2009.464. No abstract available.

PMID:
20065207
3.

Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension.

Todd S, McGuinness B, Passmore AP.

Arch Intern Med. 2010 Jan 11;170(1):107. doi: 10.1001/archinternmed.2009.463. No abstract available.

PMID:
20065208
4.

Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.

Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B.

J Am Geriatr Soc. 2013 Sep;61(9):1482-8. doi: 10.1111/jgs.12415. Epub 2013 Sep 3.

PMID:
24000874
5.

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group.

Age (Dordr). 2013 Apr;35(2):441-53. doi: 10.1007/s11357-011-9360-z. Epub 2011 Dec 28.

6.

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J; PROGRESS Collaborative Group.

Arch Intern Med. 2003 May 12;163(9):1069-75.

PMID:
12742805
7.

Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors.

Hebert PL, McBean AM, O'Connor H, Frank B, Good C, Maciejewski ML.

Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):641-8.

PMID:
23620414
8.

Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.

Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O'Donnell M, Yusuf S.

Hypertension. 2015 Mar;65(3):651-61. doi: 10.1161/HYPERTENSIONAHA.114.04568. Epub 2015 Jan 12.

9.

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.

Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.

Expert Rev Neurother. 2009 Sep;9(9):1413-31. doi: 10.1586/ern.09.89. Review.

PMID:
19769454
10.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;(8):CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
12.

Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - the Newcastle 85+ Study.

Peters R, Collerton J, Granic A, Davies K, Kirkwood T, Jagger C.

J Hypertens. 2015 Oct;33(10):2156-64. doi: 10.1097/HJH.0000000000000653.

PMID:
26237554
13.

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.

Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S; ONTARGET and TRANSCEND Investigators.

Lancet Neurol. 2011 Jan;10(1):43-53. doi: 10.1016/S1474-4422(10)70250-7. Epub 2010 Oct 25.

PMID:
20980201
14.

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ; Second Australian National Blood Pressure Study Group.

N Engl J Med. 2003 Feb 13;348(7):583-92.

15.

Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population.

Heckbert SR, Wiggins KL, Glazer NL, Dublin S, Psaty BM, Smith NL, Longstreth WT Jr, Lumley T.

Am J Hypertens. 2009 May;22(5):538-44. doi: 10.1038/ajh.2009.33. Epub 2009 Mar 5.

16.

Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.

de Jong HJ, Vandebriel RJ, Saldi SR, van Dijk L, van Loveren H, Cohen Tervaert JW, Klungel OH.

Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):835-43. doi: 10.1002/pds.3291. Epub 2012 Jun 6.

PMID:
22674737
17.

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5.

PMID:
16642542
18.

[Antihypertensive treatment and prevention of dementia].

Seux ML.

Ann Cardiol Angeiol (Paris). 1999 Sep;48(7):512-7. French.

PMID:
12555375
19.

Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension.

Schellenbaum GD, Smith NL, Heckbert SR, Lumley T, Rea TD, Furberg CD, Lyles MF, Psaty BM.

J Am Geriatr Soc. 2005 Nov;53(11):1996-2000.

PMID:
16274385
20.

Risk of Osteoporotic Fractures With Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors in Hypertensive Community-Dwelling Elderly.

Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K; Hypertension Outcome, Surveillance Team.

J Bone Miner Res. 2014 Nov;29(11):2483-8. doi: 10.1002/jbmr.2271.

Supplemental Content

Support Center